In a recent issue of Asian Journal of Psychiatry, we presented a pragmatic hypothesis that the inclusion of GAA might offer an additional benefit in profiling inflammation-oxidative stress in schizophrenia. GAA levels in the brain, cerebrospinal fluid, serum, and urine are responsive to various brain conditions.

Clinical applications of molecular hydrogen seem to favorably affect obesity-related metabolic biomarkers in peripheral tissues, yet whether H2 directly tackles obesity pathways in the brain remains elusive. We summarized several molecular targets in the hypothalamus and beyond that could be altered by H2 gas in obesity in a new paper just published in Trends in Endocrinology and Metabolism.

Our new paper published few days ago in Current Topics In Nutraceutical Research provides an update on specific nutraceuticals that are reported to modulate AGAT activity and discusses possible implications of targeting this enzyme in experimental and clinical nutrition.

Our paper on comparative molecular docking studies on creatine and guanidinoacetic acid (GAA) has been published in Journal of Chemical Research. Docking and density functional theory studies are carried out for muscle creatine kinase, and the changes in the geometries of the ligands before and after binding to the enzyme are investigated.

Our recent study published in Nutrition Research describes the effects of L-carnosine administration on various patient- and clinician-reported outcomes in a case series of patients with multiple sclerosis (MS). L-carnosine was administered orally for 8 weeks in two women and one man suffering from MS.